Prelude Therapeutics Inc
PRLD- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001678660
No open-market purchases or sales by Prelude Therapeutics Inc insiders were filed in the last 90 days; 75 institutions reported holding it in 13F filings for Q2 2026, worth $264.3M in total; no superinvestor holds it.
Q3 2025 vs. Q2 2025
How the institutions holding Prelude Therapeutics Inc changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Holders | 50 | 47 | −3 |
| Shares | 27.2M | 27.2M | −26.0K (−0.1%) |
| Value | $22.0M | $39.1M | +$17.1M (+77.8%) |
New holders (5)
Institutions that held Prelude Therapeutics Inc at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Prudential Financial Inc | 25,840 | $37.2K | 0.00% |
| HRT Financial LP | 16,901 | $24.0K | 0.00% |
| Optiver Holding B.V. | 20 | $29 | 0.00% |
| SRS Capital Advisors, Inc. | 15 | $22 | 0.00% |
| Simplex Trading, LLC | 153 | $0 | 0.00% |
Sold out (8)
Institutions that held Prelude Therapeutics Inc at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Cantor Fitzgerald, L. P. | 211,859 | $171.5K |
| Charles Schwab Investment Management Inc | 80,845 | $65.4K |
| Y-Intercept (Hong Kong) Ltd | 47,788 | $38.7K |
| Marshall Wace, LLP | 41,747 | $33.8K |
| Susquehanna International Group, LLP | 39,977 | $32.4K |
| Citadel Advisors LLC | 33,625 | $27.2K |
| Wells Fargo & Company | 297 | $240 |
| True Wealth Design, LLC | 13 | $11 |